Genmab — Maj 2025
-
Det kiksede for ham da han under sin første embedsperiode prøvede at implementere foranstaltninger som "most favored nation"-prissætning. Her stod juraen og praktikken i vejen.
-
Novo Nordisk, Eli Lilly, life science: Derfor steg aktierne på trods af nye tiltag https://proinvestor.com/boards/126340
-
Bolt Biotherapeutics Reports Q1 2025 - Collaborations with Genmab and Toray continue to progress. Genmab and Bolt have now selected a second product to advance into development, while the companies also continue research and development on additional programs. https://investors.boltbio.com/news-releases/news-release-details/bolt-biotherapeutics-reports-first-quarter-2025-financial
-
for those interested on drug pricing/Trump -
Discussing President Trump’s executive order to lower drug prices: Gottlieb on CNBC’s ‘Squawk on the Street’ https://www.aei.org/press/discussing-president-trumps-executive-order-to-lower-drug-prices-gottlieb-on-cnbcs-squawk-on-the-street/ -
AFMD der bl.a. har en oral præsentation på ASCO sidst i denne måned går sikkert konkurs https://finance.yahoo.com/news/affimed-announces-filing-opening-insolvency-121500193.html
-
GSK has also stopped development of their anti-TIGIT antibody https://www.fiercebiotech.com/biotech/gsk-axes-tigit-drug-midphase-survival-data-disappoint-promoting-partner-iteos-cut-costs
-
Acasunlimab + PD-1 Blockade: Combining Forces to Boost Anti-Tumor Immunotherapy https://www.youtube.com/watch?v=qcUcA1epnWA
-
finally found a Genmab A/S Q1 2025 Earnings Call Transcript -that is not behind a paywall - https://www.marketbeat.com/earnings/reports/2025-5-8-genmab-as-stock/
-
-
Jeg bruger denne som en app til min iPhone, der er live streaming og transskription lavet af live streaming, sikkert lavet med et eller andet whisperprogram.
-
Det er som at gå at høre podcast for investorer.
-
Undskyld jeg spammer chatten. Linket er et direkte link fra mobilappen til Genmab Q1 2025 live event med transskription. Appen er helt gratis at bruge og guf for investornørder
-
C25-regnskaber, 1. kvartal 2025: Karakterbogen https://proinvestor.com/boards/126363
-
Genmab to Present New and Updated Results from its Robust Epcoritamab (EPKINLY
) Development Program at the 2025 European Hematology Association (EHA) Congress https://ir.genmab.com/news-releases/news-release-details/genmab-present-new-and-updated-results-its-robust-epcoritamab
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind